This article traces the historical evolution of Attention Deficit/Hyperactivity Disorder (ADHD) and the controversial use of stimulants as a treatment for children diagnosed with the disorder in North America.While the children in question have exhibited similar behaviour over the last century, the diagnostic labels used to identify them have changed due largely to cultural, medical and scientific changes and discoveries. For decades, children's treatment with psychotropic drugs was sufficiently controversial that pharmaceutical companies would not finance research in the area. The only substantial source of research funding for paediatric psychopharmacology in the USA from the 1950s to the 1970s was the National Institute of Mental Health (NIMH). In 1970, the first in a long-running series of controversies erupted over children's treatment with stimulants.
Anonymous (1970) Speed in Sweden and pep in America [Editorials]. New England Journal of Medicine, 283, 760—2.
2.
Anonymous (1971) Report on the conference of the use of stimulant drugs in the treatment of behaviorally disturbed young school children. Psychopharmacological Bulletin , 7, 23—9.
3.
Anonymous (1998) Images in psychiatry: Charles Bradley, M.D., 1902—1979. American Journal of Psychiatry,155 (July), 968.
4.
APA (1968) Diagnostic and Statistical Manual of Mental Disorders (2nd edition) (Washington, DC: American Psychiatric Association ).
5.
APA (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edition) (Washington, DC: American Psychiatric Association ).
6.
APA (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edition — Revised) (Washington, DC: American Psychiatric Association).
7.
Barkley, R. (1990) Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 2nd edn ( New York: The Guilford Press).
8.
Barry, J. (2004) The Great Influenza: The Epic Story of the Deadliest Plague in History (New York: Viking ).
9.
Birch, H. (1964) Brain Damage in Children:The Biological and Social Aspects (Baltimore, MD: Williams and Wilkins).
10.
Bower, W. (1954) Chlorpromazine in psychiatric illness. New England Journal of Medicine, 251 (21 Oct.), 689—92.
11.
Bradley, C. (1937) The behavior of children receiving Benzedrine. American Journal of Psychiatry,94 (Nov.), 577—85.
12.
Bradley, C. (1950) Benzedrine and dexedrine in the treatment of children's behavior disorders. Pediatrics, 5 (Jan.), 24—37.
13.
Chess, S. (1960) Diagnosis and treatment of the hyperactive child . New York State Journal of Medicine, 60, 2379—85.
14.
Clements, S. (1966) Minimal Brain Dysfunction in Children: Terminology and Identification. Task Force 1, U.S. Department of Health, Education, and Welfare (Washington, DC: Public Health Service Publication No. 1415).
15.
Clements, S. and Peters, J. (1962) Minimal brain dysfunction in the school-age child . Archives of General Psychiatry,6, 185—97.
16.
Conners, C. (1967) The syndrome of minimal brain dysfunction: psychological aspects. Pediatric Clinics of NorthAmerica, 14 (Nov.), 749—66.
17.
Conners, C. (1980) Food Additives and Hyperactive Children (New York: Plenum).
18.
Conners, C. and Eisenberg, L. (1963) The effects of methylphenidate on symptomatology and learning in disturbed children. American Journal of Psychiatry,120 (Nov.), 458—64.
19.
Conrad, P. (1975) The discovery of hyperkinesis: notes on the medicalization of deviant behavior. Social Problems, 23, 12—21.
20.
Denhoff, E. (1971) Effects of dextroamphetamine on hyperkinetic children: a controlled double blind study. Journal of Learning Disabilities , 4, 467—9, 491—8.
21.
Denhoff, E., Laufer, M. and Holden, R. (1959) The syndromes of cerebral dysfunction. Journal of the Oklahoma State Medical Association, 52, 360—6.
22.
Drug Enforcement Administration, Department of Justice (1995, October) Methylphenidate (A Background Paper) (Washington, DC).
23.
Ebaugh, F. (1923) Neuropsychiatric sequelae of acute epidemic encephalitis in children. American Journal of Diseases of Children, 25, 89—97.
24.
Elliott, C. (2004) Better Than Well (New York: Oxford University Press).
25.
Feingold, B. (1975) Why Your Child is Hyperactive ( New York: Random House).
26.
Ferguson, J., Linn, F., Nickels, M. and Sheets, J. (1956) Methylphenidate (Ritalin) hydrochloride parenteral solution: preliminary report. Journal of theAmerican Medical Association, 162 (1 Dec.), 1303—4.
27.
Fisher, S. (ed.) (1958) Child Research in Psychopharmacology, NIMH Conference, Washington (Springfield, IL: Charles C. Thomas).
28.
Freed, H. and Peifer, C. (1956) Treatment of hyperkinetic emotionally disturbed children with prolonged administration of chlorpromazine. American Journal of Psychiatry,113 (July), 22—6.
29.
Freedman, D. (1992) The search: body, mind and human purpose. American Journal of Psychiatry,149 (July), 858—66.
30.
Freedman, A., Effron, A. and Bender, L. (1955) Pharmacotherapy in children with psychiatric illness . Journal of Nervous and Mental Disease, 122 (Nov.), 479—86.
31.
Graham, J. (1972) Amphetamine politics on Capitol Hill. Transaction: Social Science and Modern Society, 9 (Jan.), 14—22.
32.
Grinspoon, L. and Singer, S. (1973) Amphetamines in the treatment of hyperkinetic children . Harvard Education Review, 43 (Nov.), 515—55.
33.
Hentoff, N. (1970) The drugged classroom. Evergreen Review, (Dec.), 31—3.
34.
Hentoff, N. (1972) Drug-pushing in the schools. TheVillage Voice, (25 May), 20—1.
35.
Herbert, H. (1964) The concept and testing of brain damage in children: a review. Journal of Child Psychology and Psychiatry, 5, 197—217.
36.
Hohman, L. (1922) Post-encephalitic behavior disorders in children . Johns Hopkins Hospital Bulletin, 33, 372—5.
37.
Kahn, E. and Cohen, L. (1934) Organic drivenness: a brain stem syndrome and an experience with case reports. New England Journal of Medicine , 210, 748—56.
38.
Ladd, E. (1970) Pills for classroom peace?Saturday Review, (21 Nov.), 66—8, 81—3.
39.
Lakoff, A. (2000) Adaptive will: the evolution of Attention Deficit Disorder. Journal of the History of the Behavioral Sciences , 36 (Spring), 149—69.
40.
Laufer, M. (1975) In Osler's day it was syphilis. In E. Anthony (ed.), Explorations in Child Psychiatry (New York: Plenum Press), 105—24.
41.
Laufer, M. and Denhoff, E. (1957) Hyperkinetic Behavior Syndrome in children. Pediatrics, 50 (Apr.), 463—74.
42.
Laufer, M., Denhoff, E. and Solomons, G. (1957) Hyperkinetic Impulse Disorder in children's behavior problems. Psychosomatic Medicine, 19 (Jan.—Feb.), 38—49.
43.
Lehmann, H. (1989) The introduction of chlorpromazine to North America . Psychiatric Journal of the University of Ottawa, 14, 263—5.
44.
Lehmann, H. and Hanrahan, G. (1954) New inhibiting agent for psychomotor excitement and manic states. Archives of Neurology and Psychiatry, 71, 227—37.
45.
Lipman, R. (1974) NIMH-PRB support of research in minimal brain dysfunction in children. In C. Conners (ed.), Clinical Use of Stimulant Drugs in Children (Amsterdam : Excerpta Medica), 203—13.
46.
Mallett, C. (2006) Behaviorally-based disorders: the historical social construction of youths' most prevalent psychiatric diagnoses. History of Psychiatry, 17, 437—60.
47.
Mayes, R., Bagwell C. and Erkulwater, J. (forthcoming) Medicating Children: ADHD and Pediatric Mental Health (Cambridge, MA: Harvard University Press).
48.
Mayes, R. and Horwitz, A. (2005) DSM-III and the revolution in the classification of mental illness. Journal of the History of the Behavioral Sciences, 41 (Summer), 249—67.
49.
Maynard, R. (1970) Omaha pupils given `behavior drugs'. Washington Post, (29 June), 1.
50.
Molitch, M. and Sullivan, J. (1937) The effect of Benzedrine sulfate on children taking the new Stanford Achievement Test. American Journal of Orthopsychiatry , 7 (Oct.), 519—22.
51.
Rafalovich, A. (2001) The conceptual history of Attention Deficit Hyperactivity Disorder: idiocy, imbecility, encephalitis and the child deviant, 1877—1929 . Deviant Behavior: An Interdisciplinary Journal, 22, 93—115.
52.
Rafalovich, A. (2004) Framing ADHD Children: A Critical Examination of the History, Discourse, and Everyday Experience of Attention Deficit/Hyperactivity Disorder (Lanham, MD: Lexington Books).
53.
Rapin, I. (1964) Brain damage in children. In J. Brennemann (ed.), Practice of Pediatrics (Hagerstown, MD: Prior), ch. 17.
54.
Rapoport, J., Buchsbaum, M., Weingartner, H., Zahn T., Ludlow, C. and Mikkelsen, E. (1980) Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Archives of General Psychiatry,37, 933-43.
55.
Rapoport, J., Buchsbaum, M., Zahn, T., Weingartner, H., Ludlow, C. and Mikkelsen, J. (1978) Dextroamphetamine: cognitive and behavioral effects on normal prepubertal boys. Science, 199, 560—3.
56.
Report of the Conference on the Use of Stimulant Drugs in the Treatment of Behaviorally Disturbed Young Children,Washington, DC, January 11—12, 1971 (Office of Child Development and the Office of the Assistant Secretary for Health and Scientific Affairs, Department of Health, Education, and Welfare, 1971). Reprinted in Journal of Learning Disabilities , 4 (Nov. 1971), 523—30.
57.
Ross, D. and Ross, S. (1976) Hyperactivity: Research,Theory and Action (New York: John Wiley & Sons).
58.
Safer, D. (1971) Drugs for problem school children. Journal of School Health, 41 (Nov.), 491.
59.
Sandberg, S. and Barton, J. (1996) Historical development. In S. Sandberg (ed.), Hyperactivity Disorders of Childhood (Cambridge: Cambridge University Press), 1—28.
60.
Schachar, R. (1986) Hyperkinetic Syndrome: historical development of the concept. In E. Taylor (ed.), The Overactive Child, Clinics in Developmental Medicine, No. 97 (Oxford: Blackwell ), 19—40.
61.
Schrag, P. and Divoky, D. (1975) The Myth of the Hyperactive Child and Other Means of Child Control (New York: Pantheon Books).
62.
Shorter, E. (1997) A History of Psychiatry: From the Age of the Asylum to the Age of Prozac (New York: John Wiley & Sons).
63.
Smith, D. and Wesson, D. (1973) Uppers and Downers (Englewood Cliffs, NJ: Prentice-Hall).
64.
Stewart, M., Pitts, F., Craig, A. and Dieruf, W. (1966) The Hyperactive Child Syndrome. American Journal of Orthopsychiatry, 36 (Oct.), 861—7.
65.
Still, G. (1902) The Goulstonian Lectures on some abnormal psychical conditions in children. The Lancet, 1 (12 Apr.), 1008—12; (19 Apr.), 1079—82; (26 Apr.), 1163—7.
66.
Strecker, E. and Ebaugh, F. (1924) Neuropsychiatric sequelae of cerebral trauma in children. Archives of Neurology and Psychiatry, 12, 443—53.
67.
Strother, C. (1973) Minimal cerebral dysfunction: a historical overview . Annals of the New York Academy of Sciences, 205 (28 Feb.), 6—17.
68.
Swanson, J., McBurnett, K., Christian, D. and Wigal, T. (1995) Stimulant medications and the treatment of children with ADHD. In T. Ollendick and R. Prinz (eds), Advances in Clinical Child Psychology, Vol. 17 (New York : Plenum Press), 265—332.
69.
Swazey, J. (1974) Chlorpromazine in Psychiatry: A Study of Therapeutic Innovation (Cambridge, MA: MIT Press ).
70.
Tredgold, A. (1922) Mental Deficiency (Amentia), 4th edn (New York: William Wood & Company), 174—201.
71.
Wax, P. (1997) Analeptic use in clinical toxicology: a historical appraisal. Journal of Toxicology: ClinicalToxicology, 35 (Mar.), 203—9.
72.
Wender, P. (1971) Minimal Brain Dysfunction in Children ( New York: Wiley-Interscience).
73.
Werry, J. (1978) Pediatric Psychopharmacology:The Use of Behavior Modifying Drugs in Children (New York: Brunner/Mazel ).
74.
WHO [World Health Organization] (1994) Manual of International Statistical Classification of Diseases, Injuries, and Causes of Death, 10th edn ( New York: United Nations).
75.
Wortis, J. (1986) Adolph Meyer: some recollections and impressions . British Journal of Psychiatry, 149 (Dec.), 677—81.
